<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="alz14158" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Alzheimers Dement</journal-id><journal-id journal-id-type="iso-abbrev">Alzheimers Dement</journal-id><journal-id journal-id-type="pmc-domain-id">4549</journal-id><journal-id journal-id-type="pmc-domain">alzdem</journal-id><journal-id journal-id-type="publisher-id">ALZ</journal-id><journal-title-group><journal-title>Alzheimer's &amp; Dementia</journal-title></journal-title-group><issn pub-type="ppub">1552-5260</issn><issn pub-type="epub">1552-5279</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11497707</article-id><article-id pub-id-type="pmcid-ver">PMC11497707.1</article-id><article-id pub-id-type="pmcaid">11497707</article-id><article-id pub-id-type="pmcaiid">11497707</article-id><article-id pub-id-type="pmid">39129270</article-id><article-id pub-id-type="doi">10.1002/alz.14158</article-id><article-id pub-id-type="publisher-id">ALZ14158</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association of cortical morphology, white matter hyperintensity, and glymphatic function in frontotemporal dementia variants</article-title><alt-title alt-title-type="left-running-head">XIAO <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="alz14158-cr-0001" contrib-type="author"><name name-style="western"><surname>Xiao</surname><given-names initials="D">Die</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0002" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jianyu</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0003" contrib-type="author"><name name-style="western"><surname>Ren</surname><given-names initials="Z">Zhanbing</given-names></name><xref rid="alz14158-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="alz14158-cr-0004" contrib-type="author"><name name-style="western"><surname>Dai</surname><given-names initials="M">Minghui</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0005" contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="Y">Yihan</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0006" contrib-type="author"><name name-style="western"><surname>Qiu</surname><given-names initials="T">Ting</given-names></name><xref rid="alz14158-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="alz14158-cr-0007" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Huixiong</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0008" contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Yifan</given-names></name><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="alz14158-cr-0009" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Youming</given-names></name><xref rid="alz14158-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="alz14158-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><address><email>zhangym0820@csu.edu.cn</email></address></contrib><contrib id="alz14158-cr-0010" contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yuanchao</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8191-4899</contrib-id><xref rid="alz14158-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="alz14158-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>yuanchao.zhang8@gmail.com</email></address></contrib><contrib id="alz14158-cr-0011" contrib-type="author"><name name-style="western"><surname>Palaniyappan</surname><given-names initials="L">Lena</given-names></name><xref rid="alz14158-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="alz14158-cr-0012" contrib-type="author"><collab collab-type="authors">For the Frontotemporal Lobar Degeneration Neuroimaging Initiative</collab></contrib></contrib-group><aff id="alz14158-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China</institution>
<city>Chengdu</city>
<country country="CN">P. R. China</country>
</aff><aff id="alz14158-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">School of Life Science and Technology</named-content>
<institution>University of Electronic Science and Technology of China</institution>
<city>Chengdu</city>
<country country="CN">P. R. China</country>
</aff><aff id="alz14158-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>College of Physical Education, Shenzhen University</institution>
<city>Shenzhen</city>
<country country="CN">P. R. China</country>
</aff><aff id="alz14158-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Douglas Mental Health University Institute</institution>
<institution>McGill University</institution>
<city>Montreal</city>
<country country="CA">Canada</country>
</aff><aff id="alz14158-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>Xiangya Hospital</institution>
<institution>Central South University</institution>
<city>Changsha</city>
<country country="CN">P. R. China</country>
</aff><aff id="alz14158-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">National Clinical Research Center for Geriatric Diseases</named-content>
<institution>Xiangya Hospital</institution>
<institution>Central South University</institution>
<city>Changsha</city>
<named-content content-type="country-part">Hunan</named-content>
<country country="CN">P. R. China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Yuanchao Zhang, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.<break/> Email: <email>yuanchao.zhang8@gmail.com</email><break/>Youming Zhang, Department of Radiology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P. R. China.<break/> Email: <email>zhangym0820@csu.edu.cn</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2024</year></pub-date><volume>20</volume><issue seq="160">9</issue><issue-id pub-id-type="pmc-issue-id">473307</issue-id><issue-id pub-id-type="doi">10.1002/alz.v20.9</issue-id><fpage>6045</fpage><lpage>6059</lpage><history><date date-type="rev-recd"><day>13</day><month>4</month><year>2024</year></date><date date-type="received"><day>17</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>24</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-24 11:25:16.703"><day>24</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">© 2024 The Author(s). <italic toggle="yes">Alzheimer's &amp; Dementia</italic> published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ALZ-20-6045.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:ALZ-20-6045.pdf"/><abstract><title>Abstract</title><sec id="alz14158-sec-0010"><title>INTRODUCTION</title><p>Frontotemporal dementia (FTD) can be phenotypically divided into behavioral variant FTD (bvFTD), nonfluent variant primary progressive aphasia (nfvPPA), and semantic variant PPA (svPPA). However, the neural underpinnings of this phenotypic heterogeneity remain elusive.</p></sec><sec id="alz14158-sec-0020"><title>METHODS</title><p>Cortical morphology, white matter hyperintensities (WMH), diffusion tensor image analysis along the perivascular space (DTI‐ALPS), and their interrelationships were assessed in subtypes of FTD. Neuroimaging‐transcriptional analyses on the regional cortical morphological deviances among subtypes were also performed.</p></sec><sec id="alz14158-sec-0030"><title>RESULTS</title><p>Changes in cortical thickness, surface area, gyrification, WMH, and DTI‐ALPS were subtype‐specific in FTD. The three morphologic indices are related to whole‐brain WMH volume and cognitive performance, while cortical thickness is related to DTI‐ALPS. Neuroimaging‐transcriptional analyses identified key biological pathways linked to the formation and/or spread of TDP‐43/tau pathologies.</p></sec><sec id="alz14158-sec-0040"><title>DISCUSSION</title><p>We found subtype‐specific changes in cortical morphology, WMH, and glymphatic function in FTD. Our findings have the potential to contribute to the development of personalized predictions and treatment strategies for this disorder.</p></sec><sec id="alz14158-sec-0050"><title>Highlights</title><p>
<list list-type="bullet" id="alz14158-list-0001"><list-item><p>Cortical morphologic changes, white matter hyperintensities (WMH), and glymphatic dysfunction are subtype‐specific.</p></list-item><list-item><p>Cortical morphologic changes, WMH, and glymphatic dysfunction are inter‐correlated.</p></list-item><list-item><p>Cortical morphologic changes and WMH burden contribute to cognitive impairments.</p></list-item></list>
</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="alz14158-kwd-0001">cortical morphology</kwd><kwd id="alz14158-kwd-0002">frontotemporal dementia</kwd><kwd id="alz14158-kwd-0003">glymphatic function</kwd><kwd id="alz14158-kwd-0004">MRI</kwd><kwd id="alz14158-kwd-0005">neuroimaging‐transcriptional association</kwd><kwd id="alz14158-kwd-0006">white matter hyperintensities</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82001784</award-id></award-group><award-group id="funding-0002"><funding-source>Natural Science Foundation (Youth Science Foundation Project) of Hunan Province</funding-source><award-id>2021JJ41054</award-id></award-group><award-group id="funding-0003"><funding-source>Youth Science Foundation of Xiangya Hospital</funding-source><award-id>2019Q16</award-id></award-group><award-group id="funding-0004"><funding-source>Key Platform Project of Department of Education of Guangdong Province</funding-source><award-id>2022ZDZX2086</award-id></award-group><award-group id="funding-0005"><funding-source>Incubation Program for Innovative Science and Technology in UESTC</funding-source><award-id>Y03023206100209</award-id></award-group><award-group id="funding-0006"><funding-source>Scientific research program of Xi'an Health Commission</funding-source><award-id>2020QN03</award-id></award-group><award-group id="funding-0007"><funding-source>Fonds de recherche du Québec‐Santé (FRQS)</funding-source><award-id>CB‐C2022</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="15"/><word-count count="8047"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.9 mode:remove_FC converted:23.10.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="alz14158-cit-0059"><string-name name-style="western"><surname>Xiao</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Z</given-names></string-name>, et al.; <collab collab-type="authors">For the Frontotemporal Lobar Degeneration Neuroimaging Initiative</collab>
. <article-title>Association of cortical morphology, white matter hyperintensity, and glymphatic function in frontotemporal dementia variants</article-title>. <source>Alzheimer's Dement</source>. <year>2024</year>;<volume>20</volume>:<fpage>6045</fpage>–<lpage>6059</lpage>. <pub-id pub-id-type="doi">10.1002/alz.14158</pub-id><pub-id pub-id-type="pmcid">PMC11497707</pub-id><pub-id pub-id-type="pmid">39129270</pub-id></mixed-citation>
</p><fn-group><fn id="alz14158-note-0001" fn-type="equal"><p>Die Xiao, Jianyu Li, and Zhanbing Ren contributed equally to this study and should be considered co‐first authors.</p></fn></fn-group></notes></front><body><sec id="alz14158-sec-0060"><label>1</label><title>INTRODUCTION</title><p>Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder characterized by a wide spectrum of clinical manifestations including behavioral, lingual, and executive‐functional deficits.<xref rid="alz14158-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Based on the dominant clinical manifestations, patients with FTD can be classified into three subtypes: the behavioral variant FTD (bvFTD), the nonfluent variant primary progressive aphasia (nfvPPA), and the semantic variant PPA (svPPA).<xref rid="alz14158-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Among them, the bvFTD subtype is characterized by apathy, lack of empathy, impulsivity, and execution‐oriented cognitive dysfunction; the nfvPPA subtype is characterized by linguistic difficulties including hesitant speech, agrammatism, and dysarthria; and the svPPA subtype is characterized by semantic dysfunctions such as impaired object recognition, dyslexia, and difficulty in naming.<xref rid="alz14158-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="alz14158-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="alz14158-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="alz14158-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Besides the distinctive clinical presentations, the three FTD subtypes also differ in terms of the severity of functional impairments,<xref rid="alz14158-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="alz14158-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> clinical courses, and prognostic outcomes.<xref rid="alz14158-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="alz14158-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="alz14158-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> For example, patients with the bvFTD subtype are often associated with more pronounced functional disabilities, faster clinical progression, and shorter survival relative to the other two subtypes,<xref rid="alz14158-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="alz14158-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> suggesting disparate neural substrates among subtypes.</p><p>Neuroimaging studies have revealed divergent gray matter volume (GMV) reductions in the three subtypes, with the bvFTD subtype mainly involving the frontal and anterior temporal lobes, the svPPA subtype mainly involving the anterior temporal lobe, and the nfvPPA subtype mainly involving the inferior frontal and insular regions.<xref rid="alz14158-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="alz14158-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> However, the interpretation of GMV changes assessed using voxel‐based morphometry can be difficult because GMV is a mixture of cortical thickness, surface area, and/or cortical folding.<xref rid="alz14158-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="alz14158-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Indeed, the three constituent components of GMV are both phenotypically and genetically independent and likely to be affected by different neuropathologic events.<xref rid="alz14158-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> No prior studies have simultaneously characterized the subtype‐specific changes in the three morphological features of FTD. Studies as such may provide new insights into the neural mechanisms underlying the clinical heterogeneity of this disorder.</p><p>Apart from the GM changes, studies have uncovered divergent white matter (WM) abnormalities in FTD subtypes.<xref rid="alz14158-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="alz14158-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> For example, a recent study reported varying degrees of WM lesions among FTD subtypes, with the bvFTD subtype exhibiting more severe WM hyperintensities (WMH) than other subtypes.<xref rid="alz14158-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="alz14158-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Meanwhile, FTD patients with <italic toggle="yes">GRN</italic> gene mutation were prone to have more severe WMH than those without, suggesting a genetic basis for the WM lesions.<xref rid="alz14158-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="alz14158-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Questions however remain unanswered as to whether and how WM lesions and cortical morphological abnormalities in FTD are spatially and causally related. Considering the essential role of WM in metabolite provision,<xref rid="alz14158-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> signal transduction,<xref rid="alz14158-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> and neurotrophic support to GM,<xref rid="alz14158-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> elucidating the interplay between WM lesions and GM morphological abnormalities may uncover potential mechanistic pathways mediating these endophenotypic abnormalities in FTD.</p><p>Recent studies have found that changes in GM and WM are tightly linked to a disrupted glymphatic system,<xref rid="alz14158-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> which plays crucial roles in the removal of neurotoxic protein aggregates in neurodegenerative diseases.<xref rid="alz14158-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> In FTD, around half of cases are accompanied by neuronal inclusions of toxic TAR DNA‐binding protein 43 (TDP‐43) aggregates, while 36%–50% of cases are accompanied by aggregation of hyperphosphorylated tau proteins.<xref rid="alz14158-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="alz14158-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Neuropathologic abnormalities as such have been linked to glymphatic dysfunction that occurs as a result of AQP4 polarization and vascular defects.<xref rid="alz14158-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="alz14158-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Moreover, studies also found a significant spatial overlapping between regions with trapped contrast agents along perivascular space and cortical regions with profound proteinopathy in FTD.<xref rid="alz14158-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="alz14158-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Intriguingly, a recent study demonstrated abnormal glymphatic function in the bvFTD variant using diffusion tensor image analysis along the perivascular space (DTI‐ALPS) index.<xref rid="alz14158-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Whether changes in the glymphatic system are subtype‐specific and related to GM and WM abnormalities in FTD remain unknown.</p><p>This study aimed to investigate the subtype‐specific changes in cortical morphology, WMH, glymphatic function, and their associations in FTD. We hypothesized that (1) cortical morphological changes, severity of WMH, and glymphatic dysfunctions would be subtype‐specific in FTD, with the bvFTD subtype exhibiting the most prominent changes; (2) cortical morphological changes would relate to whole‐brain WMH volume and DTI‐ALPS in FTD; (3) the neural underpinnings of cortical morphological deviations among FTD subtypes would encompass biological processes/pathways critical for the development and spread of TDP‐43 and/or tau pathologies.</p></sec><sec id="alz14158-sec-0070"><label>2</label><title>MATERIALS AND METHODS</title><sec id="alz14158-sec-0080"><label>2.1</label><title>Participants</title><p>Participants enrolled in the Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI) <underline underline-style="single">(https://4rtni‐ftldni.ini.usc.edu/)</underline> were considered for inclusion in this study. The FTLDNI database is a multicentric database that collects Positron Emission Tomography (PET), MRI, and Cerebrospinal Fluid (CSF) biomarkers of patients with FTD and matched healthy controls (HCs). Patients with FTD were diagnosed according to the Neary criteria. Exclusion criteria for FTD patients included major psychiatric or neurologic comorbidity, sustained hypertension, and vascular diseases.<xref rid="alz14158-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> The severity of cognitive impairment and clinical dementia in patients with FTD was assessed using the Mini‐Mental State Examination (MMSE) and the Clinical Dementia Rating (CDR) scales, respectively. Inclusion criteria for HCs encompassed cognitive normality, as indicated by a CDR score of 0 and an MMSE score ranging from 26 to 30, along with normal physical health and no prior history of mental illness.<xref rid="alz14158-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> After excluding patients with poor image quality, inaccurate cortical surface reconstruction, and local gyrification index (LGI) computational errors, a total of 122 FTD patients were included in this study, consisting of 56 bvFTD, 30 svPPA, and 36 nfvPPA. Considering the significant differences in age and sex composition among the three subtypes, we meticulously selected three age‐ and sex‐matched control groups, comprising a total of 101 HCs from the FTLDNI database, for comparison with each FTD subtype.</p></sec><sec id="alz14158-sec-0090"><label>2.2</label><title>MRI data acquisition</title><p>The multimodal MRI data were acquired at distinct locations using a Siemens 3.0T Tim Trio scanner with a 12‐channel receiver head coil. T1‐weighted MRI data were collected using a three‐dimensional magnetization‐prepared rapid gradient‐echo sequence with the following parameters: repetition time (TR) = 2300 ms, echo time (TE) = 2.98 ms, flip angle = 9°, slice thickness = 1 mm, voxel size = 1 × 1 × 1 mm<sup>3</sup>. T2‐weighted MRI data were collected using a fluid‐attenuated inversion recovery sequence with the following parameters: TR = 6000 ms, TE = 389 ms, inversion time = 2100 ms, flip angle = 120°, slice thickness = 1 mm, voxel size = 1 × 1 × 1 mm<sup>3</sup>. Diffusion‐weighted MRI data were collected using a single‐shot echo‐planar imaging sequence with the following parameters: <italic toggle="yes">b</italic>‐value = 0, 1000 s/mm<sup>2</sup>, gradient directions = 44, TR = 9200 ms, TE = 82 ms, slice thickness = 2.7 mm, voxel size = 2.73 × 2.73 × 2.70 mm<sup>3</sup>, phase encoding direction = anterior‐posterior.</p><boxed-text position="float" content-type="box" orientation="portrait"><sec id="alz14158-sec-0100"><title>RESEARCH IN CONTEXT</title><p>
<list list-type="order" id="alz14158-list-0002"><list-item><p>
<bold>Systematic review</bold>: We systematically reviewed the literature on frontotemporal dementia (FTD) using PubMed. No studies have simultaneously examined the subtype‐specific changes in cortical thickness, surface area, and gyrification in FTD. Additionally, there is a lack of research investigating the associations of morphological changes with white matter hyperintensities (WMH), glymphatic dysfunction, and their transcriptional correlates in FTD.</p></list-item><list-item><p>
<bold>Interpretation</bold>: This study revealed that changes in three independent morphological features (thickness, surface area, and gyrification), severity of WMH, and glymphatic dysfunction in FTD are not only subtype‐specific but also inter‐related. These findings are corroborated by neuroimaging‐transcriptional analysis that implicates biological processes/pathways relevant to proteinopathy, white matter pathology, and glymphatic dysfunction in FTD.</p></list-item><list-item><p>
<bold>Future directions</bold>: The characterization of the subtype‐specific changes in multiple imaging parameters and their inter‐correlations is important in the understanding of FTD variants pathophysiology, and in the development of tailored treatment strategies for the three FTD variants.</p></list-item></list>
</p></sec></boxed-text></sec><sec id="alz14158-sec-0110"><label>2.3</label><title>Cortical morphological analyses</title><p>T1‐weighted MRI data were processed using FreeSurfer (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://surfer.nmr.mgh.harvard.edu/" ext-link-type="uri">http://surfer.nmr.mgh.harvard.edu/</ext-link>) to obtain each participant's cortical thickness, surface area and LGI maps. In brief, the T1‐weighted images were segmented to identify the gray/white matter boundary, which was further tessellated and topologically corrected to generate a refined surface representation of the boundary (i.e., the white surface). This surface was used as the initial shape for a deformable model to reconstruct the pial surface. From these cortical surfaces, we can derive the three cortical morphological indices. Specifically, the cortical thickness map was obtained by measuring the distance between the pial and white surfaces; the cortical surface area map was computed by allocating one‐third of the area of each triangle to each of its vertices; the LGI map was computed by measuring the ratio of the pial surface area to the outer hull surface area in a vertex‐wise fashion across the cerebral cortex. The maps of cortical thickness, surface area, and LGI were resampled onto the “fsaverage” template in FreeSurfer and then smoothed using Gaussian‐kernels with full‐width‐at‐half‐maximum (FWHM) of 20, 20, and 15 mm, respectively. We chose a lower FWHM for LGI as LGI is an inherently smoothed metric.<xref rid="alz14158-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="alz14158-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Prior to statistical analysis, all the surfaces used for the calculation of the morphological indices were visually checked. Participants with poor surface reconstruction or LGI calculation error in at least one cortical hemisphere were excluded. The number of excluded participants, along with the specific reason for their exclusion, can be found in <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">supplementary methods</xref>.</p><p>Vertex‐wise contrast of cortical thickness, surface area, and LGI maps were carried out between each FTD subtype and their matched healthy controls using SurfStat package (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.math.mcgill.ca/keith/surfstat/" ext-link-type="uri">http://www.math.mcgill.ca/keith/surfstat/</ext-link>). For every vertex, a general linear model (GLM) was applied with covariates including age, sex, and group. Clusters of interest were firstly defined using a vertex‐wise <italic toggle="yes">p</italic> &lt; 0.001 and then corrected for multiple comparisons across the entire brain at the cluster level using random field theory (RFT).<xref rid="alz14158-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> The significance level for these clusters was set at <italic toggle="yes">p</italic> &lt; 0.05 after multiple‐comparison correction.</p><p>To examine the morphological differences among the three subtypes, vertex‐wise analysis of covariance (ANCOVA) was conducted respectively for cortical thickness, surface area, and LGI using SurfStat package with age and sex as covariates of no interest. Clusters of interest were firstly defined using a vertex‐wise <italic toggle="yes">p</italic> &lt; 0.001 and then corrected for multiple comparisons across the entire brain at the cluster level using RFT. The significance level for these clusters was set at <italic toggle="yes">p</italic> &lt; 0.05 after multiple‐comparison correction. To explore the confounding effect of WMH burden on the between‐group comparisons, we replicated the above surface‐based analyses while incorporating whole‐brain WMH volume as an additional covariate of no interest.</p><p>Using the pooled data of the three subtypes, we computed the Spearman's partial correlation coefficient between the global mean value of each of the three morphological indices and the clinical measurements (the CDR and MMSE scores) while adjusting for age and sex as covariates of no interest.</p></sec><sec id="alz14158-sec-0120"><label>2.4</label><title>WMH analysis</title><p>WMH volumes were measured using a fully automated toolbox, UBO Detector.<xref rid="alz14158-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Briefly, individual T2 images were first registered to their corresponding T1 images. Tissue segmentation was then conducted, and the Diffeomorphic Anatomical Registration Through Exponentiated Lie (DARTEL) algorithm was employed to warp the T1 images onto a study‐specific template in the DARTEL space. To warp the T2 images onto the same DARTEL template, the field maps generated by warping individual T1 images to the DARTEL space were applied to the T2 images that had already been registered to the T1 images. Following the removal of non‐brain tissue and correction for bias field on the T2 images in DARTEL space, a supervised machine learning algorithm, k‐nearest neighbor (k‐NN), was employed to identify the WMH clusters, which were further categorized based on their anatomic location into periventricular, deep, frontal, temporal, parietal, and occipital WMH. The quality control HTML webpages generated by UBO Detector during the registration, segmentation, and extraction of WMH were meticulously reviewed and evaluated by an experienced radiologist (Y.M. Zhang) to detect any potential processing errors. Prior to statistical analysis, the WMH volumes were log‐transformed to improve the normality of their distribution.</p><p>WMH volumes for a particular brain region and the whole brain were compared between each subtype and their matched HCs as well as among the three FTD subtypes using the GLM in SPSS, with age and sex as covariates of no interest. Using the pooled data of the three subtypes, we computed Spearman's partial correlation coefficient between whole‐brain WMH volume and clinical measurements (the CDR and MMSE scores) while adjusting for age and sex as covariates of no interest.</p></sec><sec id="alz14158-sec-0130"><label>2.5</label><title>DTI‐ALPS analysis</title><p>DTI‐ALPS index was computed from DTI data to assess the glymphatic function of each participant. Briefly, DTI data were denoised, head movement and eddy current corrected. The fractional anisotropy (FA) and x‐axis, y‐axis, and z‐axis diffusivity maps were estimated and transformed into the JHU‐ICBM‐FA template space<xref rid="alz14158-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> using linear and nonlinear registration tools in FSL. The projection and association fibers (i.e., the superior corona radiata [SCR] and the superior longitudinal fasciculus [SLF]) at the level of lateral ventricle body were identified based on the JHU‐ICBM‐DTI‐81‐white‐matter Labeled Atlas. Four 5 mm‐diameter spherical masks located in the areas of bilateral SCR and SLF were created and applied to each participant's diffusivity maps. The mean diffusivity values in the x‐axis (Dxx), y‐axis (Dyy), and z‐axis (Dzz) of the masks on projection and association fibers were computed and denoted respectively as Dxx<italic toggle="yes">proj</italic>, Dyy<italic toggle="yes">proj</italic>, Dzz<italic toggle="yes">proj</italic>, Dxx<italic toggle="yes">assoc</italic>, Dyy<italic toggle="yes">assoc</italic>, and Dzz<italic toggle="yes">assoc</italic>. Subsequently, the DTI‐ALPS index can be calculated as a ratio of [(Dxx<italic toggle="yes">proj</italic> + Dxx<italic toggle="yes">assoc</italic>) / (Dyy<italic toggle="yes">proj</italic> + Dzz<italic toggle="yes">assoc</italic>)].<xref rid="alz14158-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> The diffusion maps for each participant were visually checked to identify and exclude any potential processing errors or images with poor quality (see <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">supplementary methods</xref>).</p><p>Contrasts of the DTI‐ALPS index were carried out between each subtype and their matched HCs as well as among the three FTD subtypes using the GLM in SPSS, with age and sex as covariates of no interest. Using the pooled data of the three subtypes, we computed Spearman's partial correlation coefficient between the DTI‐ALPS index and clinical measurements (the CDR and MMSE scores) while adjusting for age and sex as covariates of no interest.</p></sec><sec id="alz14158-sec-0140"><label>2.6</label><title>Intermodal correlation analyses</title><p>Spearman's correlation coefficient was computed using the pooled data of the three subtypes to examine the associations among the global mean value of each morphological index, the whole‐brain WMH volume, and the DTI‐ALPS index. The correlation analyses were further corrected for multiple comparisons using the false discovery rate (FDR) method. Using the “mediation toolbox” within Matlab, we also explored the mediated relationships among the imaging and clinical measurements in FTD.</p></sec><sec id="alz14158-sec-0150"><label>2.7</label><title>Neuroimaging‐transcriptional association analysis</title><p>A neuroimaging‐transcription association analysis was performed to explore the potential biological pathways accounting for the morphological deviances among the FTD subtypes. Specifically, the mean <italic toggle="yes">f</italic>‐value for each of the 68 cortical regions of the Desikan–Killiany Atlas was extracted from the F‐map of the aforementioned vertex‐wise analysis of covariance (ANCOVA) respectively for the three morphological indices, resulting in three 68 ×1 vectors of regional morphologic deviance. Next, gene expression data were extracted from the Allen Human Brain Atlas transcriptomic dataset and mapped onto 68 cortical regions of the Desikan–Killiany Atlas using the abagen toolbox (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/rmarkello/abagen" ext-link-type="uri">https://github.com/rmarkello/abagen</ext-link>), resulting in a 68×16533 regional transcription matrix. Subsequently, a partial least square (PLS) regression was conducted to explore the association between regional transcription data and each of the three regional morphologic deviance vectors, with the regional transcription data as the predictor variables and the regional morphologic deviance vector as the response variable. Using PLS regression, we can maximize the covariance between predictor and response variables and identify a set of latent components. In neuroimaging transcriptomic analysis, the first component (PLS1) represents the linear combination weights of the gene expression data that best predict the neuroimaging feature across regions. A permutation test with 1000 replications was used to evaluate the statistical significance of PLS1. The error estimating each gene's PLS1 weight was measured through bootstrapping (resampling the 68 cortical regions 1000 times with replacement). A <italic toggle="yes">Z</italic>‐score was then calculated for each gene as the ratio of the weight to its bootstrap standard deviation. Genes with a <italic toggle="yes">Z</italic>‐score &gt; 4 for each of the three morphological indices, indicative of pronounced morphological deviances among subtypes, were amalgamated for subsequent enrichment analysis. After obtaining these genetic ‘hits’, we used Metascape (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://metascape.org/" ext-link-type="uri">https://metascape.org/</ext-link>) to calculate enrichments of gene ontology (GO) biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.</p></sec></sec><sec id="alz14158-sec-0160"><label>3</label><title>RESULTS</title><sec id="alz14158-sec-0170"><label>3.1</label><title>Demographic and clinical characteristics</title><p>The demographic and clinical data of all the participants were displayed in Table <xref rid="alz14158-tbl-0001" ref-type="table">1</xref>. There was no significant difference in age and sex composition between each subtype and their matched HCs (<italic toggle="yes">p</italic> &gt; 0.05). There were significant differences in sex composition and CDR scores among the three subtypes of FTD (<italic toggle="yes">p</italic> &lt; 0.001), with the bvFTD subtype having higher CDR scores than the nfvPPA (Cohen's <italic toggle="yes">d</italic> = 1.371) and svPPA subtypes (Cohen's <italic toggle="yes">d</italic> = 0.728). There was no significant difference in the age and MMSE scores among the three subtypes (<italic toggle="yes">p</italic> &gt; 0.05).</p><table-wrap position="float" id="alz14158-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Demographic and clinical data for patients with FTD and healthy controls</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">bvFTD</th><th align="left" rowspan="1" colspan="1">svPPA</th><th align="left" rowspan="1" colspan="1">nfvPPA</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>‐Value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">FTD patients</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sex, M:F</td><td align="left" rowspan="1" colspan="1">37:19</td><td align="left" rowspan="1" colspan="1">15:15</td><td align="left" rowspan="1" colspan="1">17:19</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="left" rowspan="1" colspan="1">60.71 ± 6.69</td><td align="left" rowspan="1" colspan="1">63.23 ± 6.46</td><td align="left" rowspan="1" colspan="1">67.97 ± 7.24</td><td align="left" rowspan="1" colspan="1">0.150</td></tr><tr><td align="left" rowspan="1" colspan="1">CDR</td><td align="left" rowspan="1" colspan="1">5.74 ± 2.89</td><td align="left" rowspan="1" colspan="1">3.82 ± 2.10</td><td align="left" rowspan="1" colspan="1">2.16 ± 2.10</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">24.16 ± 4.35</td><td align="left" rowspan="1" colspan="1">24.25 ± 5.36</td><td align="left" rowspan="1" colspan="1">25.64 ± 4.11</td><td align="left" rowspan="1" colspan="1">0.244</td></tr><tr><td align="left" rowspan="1" colspan="1">Healthy controls</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sex, M: F</td><td align="left" rowspan="1" colspan="1">34:19</td><td align="left" rowspan="1" colspan="1">15:15</td><td align="left" rowspan="1" colspan="1">16:19</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="left" rowspan="1" colspan="1">61.15 ± 6.58</td><td align="left" rowspan="1" colspan="1">62.83 ± 6.20</td><td align="left" rowspan="1" colspan="1">67.49 ± 6.99</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="alz14158-tbl1-note-0001"><p>Abbreviations: bvFTD, behavioral variant frontotemporal dementia; CDR, Clinical Dementia Rating; FTD, frontotemporal dementia; MMSE, Mini‐Mental State Examination; nfvPPA, nonfluent variant primary progressive aphasia; svPPA, semantic variant primary progressive aphasia.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="alz14158-sec-0180"><label>3.2</label><title>Cortical morphologic changes in variants of FTD</title><p>Compared with HCs, the bvFTD subtype showed decreased cortical thickness in the bilateral medial and lateral frontal lobe, lateral temporal and anterior medial temporal cortices, supramarginal gyri, inferior parietal lobule, as well as the anterior and posterior cingulate and precuneus (Figure <xref rid="alz14158-fig-0001" ref-type="fig">1A</xref>); the nfvPPA subtype showed decreased cortical thickness in the bilateral middle and superior frontal cortices, supramarginal gyri, left precentral gyrus, precuneus, anterior inferior temporal cortex, middle temporal, and right superior temporal cortices (Figure <xref rid="alz14158-fig-0001" ref-type="fig">1B</xref>); the svPPA subtype showed decreased cortical thickness in the bilateral inferior frontal, insular, and medial and lateral anterior temporal cortices (Figure <xref rid="alz14158-fig-0001" ref-type="fig">1C</xref>). The corresponding effect size maps of the between‐group contrasts of cortical thickness were shown in Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S1</xref>. The inclusion of WMH as an additional confounding covariate had minimal effects on the results of the between‐group contrasts (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><fig position="float" fig-type="FIGURE" id="alz14158-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Cortical thickness reductions in variants of frontotemporal dementia (FTD). Brain regions showing significantly reduced cortical thickness in the bvFTD (A), nfvPPA (B), and svPPA (C) subtypes compared with matched healthy controls (HCs). The results were corrected for multiple comparisons using random field theory (RFT). The level of significance was set at RFT‐corrected <italic toggle="yes">p</italic> &lt; 0.05. The color bar denotes the <italic toggle="yes">t</italic>‐value of the significant clusters of the corresponding contrast</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="ALZ-20-6045-g004.jpg"/></fig><p>Compared with HCs, the bvFTD subtype showed decreased surface area in the bilateral lateral frontal and lateral anterior temporal cortices (Figure <xref rid="alz14158-fig-0002" ref-type="fig">2A</xref>); the nfvPPA subtype showed decreased surface area in the bilateral inferior frontal, left orbitofrontal, precentral cortices (Figure <xref rid="alz14158-fig-0002" ref-type="fig">2B</xref>); the svPPA subtype showed decreased surface area in the bilateral inferior frontal, medial and lateral anterior temporal cortices, and left anterior insular cortex (Figure <xref rid="alz14158-fig-0002" ref-type="fig">2C</xref>). The corresponding effect size maps of the between‐group contrasts of surface were shown in Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S3</xref>. The inclusion of WMH as an additional confounding covariate had minimal effects on the results of the between‐group contrasts (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S4</xref>).</p><fig position="float" fig-type="FIGURE" id="alz14158-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Cortical surface area reductions in variants of frontotemporal dementia (FTD). Brain regions showing significantly reduced cortical surface area in the bvFTD (A), nfvPPA (B), and svPPA (C) subtypes compared with matched healthy controls (HCs). The results were corrected for multiple comparisons using random field theory (RFT). The level of significance was set at RFT‐corrected <italic toggle="yes">p</italic> &lt; 0.05. The color bar denotes the <italic toggle="yes">t</italic>‐value of the significant clusters of the corresponding contrast</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="ALZ-20-6045-g005.jpg"/></fig><p>Compared with HCs, the bvFTD subtype showed decreased LGI in the bilateral middle frontal, orbitofrontal, pre‐ and post‐central, supramarginal, inferior parietal, superior and middle temporal cortices (Figure <xref rid="alz14158-fig-0003" ref-type="fig">3A</xref>); the nfvPPA subtype showed LGI decline in the left posterior cingulate and isthmus, right precentral cortices (Figure <xref rid="alz14158-fig-0003" ref-type="fig">3B</xref>); the svPPA subtype showed decreases in the bilateral orbitofrontal, left inferior frontal, insular superior middle temporal, parahippocampal, inferior parietal, and right middle temporal cortices (Figure <xref rid="alz14158-fig-0003" ref-type="fig">3C</xref>). The corresponding effect size maps of the between‐group contrasts of LGI were shown in Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S5</xref>. The inclusion of WMH as an additional confounding covariate had minimal effects on the results of the between‐group contrasts (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S6</xref>).</p><fig position="float" fig-type="FIGURE" id="alz14158-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Local gyrification index (LGI) changes in variants of frontotemporal dementia (FTD). Brain regions showing significantly reduced LGI in the bvFTD (A), nfvPPA (B), and svPPA (C) subtypes compared with matched healthy controls (HCs). The results were corrected for multiple comparisons using random field theory (RFT). The level of significance was set at RFT‐corrected <italic toggle="yes">p</italic> &lt; 0.05. The color bar denotes the <italic toggle="yes">t</italic>‐value of the significant clusters of the corresponding contrast</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="ALZ-20-6045-g001.jpg"/></fig><p>ANCOVA among the three subtypes revealed significant cortical thickness differences in bilateral medial and lateral frontal lobe, lateral temporal and anterior medial temporal cortices, right supramarginal gyrus and inferior parietal lobule, anterior and posterior cingulate and precuneus (Figure <xref rid="alz14158-fig-0004" ref-type="fig">4A</xref>), significant surface area differences in bilateral middle frontal, left anterior lateral and medial temporal, right temporal pole (Figure <xref rid="alz14158-fig-0004" ref-type="fig">4B</xref>), and significant LGI differences in left gyrus rectus, right middle inferior and frontal, post‐and pre‐central cortices (Figure <xref rid="alz14158-fig-0004" ref-type="fig">4C</xref>). The inclusion of WMH as an additional confounding covariate had minimal effects on the results of the between‐group contrasts (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S7</xref>).</p><fig position="float" fig-type="FIGURE" id="alz14158-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Brain regions with subtypes‐specific patterns in cortical thickness (A), surface area (B), and local gyrification index (LGI) (C) in frontotemporal dementia (FTD). The results were corrected for multiple comparisons using random field theory (RFT). The level of significance was set at RFT‐corrected <italic toggle="yes">p</italic> &lt; 0.05. The color bar indicates the <italic toggle="yes">f</italic>‐value for the significant clusters of the vertex‐wise analysis of covariance (ANCOVA) among the three FTD subtypes</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="ALZ-20-6045-g002.jpg"/></fig></sec><sec id="alz14158-sec-0190"><label>3.3</label><title>WMH burdens in variants of FTD</title><p>Compared with HCs, the bvFTD subtype showed higher volumes of WMH across the whole brain (<italic toggle="yes">p</italic> = 0.001, Cohen's <italic toggle="yes">d</italic> = 0.595), periventricular WM (<italic toggle="yes">p</italic> = 0.001, Cohen's <italic toggle="yes">d</italic> = 0.582), deep WM (<italic toggle="yes">p</italic> = 0.002, Cohen's <italic toggle="yes">d</italic> = 0.574), left frontal lobe (<italic toggle="yes">p</italic> = 0.006, Cohen's <italic toggle="yes">d</italic> = 0.492), right frontal lobe (<italic toggle="yes">p</italic> = 0.003, Cohen's <italic toggle="yes">d</italic> = 0.546), left temporal lobe(<italic toggle="yes">p</italic> &lt; 0.001, Cohen's <italic toggle="yes">d</italic> = 0.751), right temporal lobe (<italic toggle="yes">p</italic> &lt; 0.001, Cohen's <italic toggle="yes">d</italic> = 0.795), left parietal lobe (<italic toggle="yes">p</italic> = 0.011, Cohen's <italic toggle="yes">d</italic> = 0.454), right parietal lobe (<italic toggle="yes">p</italic> = 0.035, Cohen's <italic toggle="yes">d</italic> = 0.373), left occipital lobe (<italic toggle="yes">p</italic> = 0.030, Cohen's <italic toggle="yes">d</italic> = 0.405) and right occipital lobe (<italic toggle="yes">p</italic> = 0.008, Cohen's <italic toggle="yes">d</italic> = 0.506); the svPPA showed higher volumes of WMH across the periventricular WM (<italic toggle="yes">p</italic> = 0.036, Cohen's <italic toggle="yes">d</italic> = 0.560) and left temporal lobe (<italic toggle="yes">p</italic> = 0.017, Cohen's <italic toggle="yes">d</italic> = 0.649) (Table <xref rid="alz14158-tbl-0002" ref-type="table">2</xref>). No significant differences in WMH volumes were observed between the nfvPPA subtype and its corresponding matched HCs. ANCOVA among the three subtypes revealed significant differences in the WMH volumes of the whole brain, periventricular WM, Deep WM, frontal lobe, temporal lobe, parietal lobe, and right occipital lobe, overall showing the most severe WM lesions in the bvFTD subtype and the least severe WM lesions in the nfvPPA subtype (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S8</xref>).</p><table-wrap position="float" id="alz14158-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>WMH volumes in patients with FTD compared with healthy controls</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">bvFTD</th><th align="left" rowspan="1" colspan="1">svPPA</th><th align="left" rowspan="1" colspan="1">nfvPPA</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>‐Value</th></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1">FTD patients [log(1+WMH volume)]</td></tr><tr><td align="left" rowspan="1" colspan="1">Whole brain</td><td align="left" rowspan="1" colspan="1">
<bold>3.53 (3.30, 3.94)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">3.47 (3.33, 3.67)</td><td align="left" rowspan="1" colspan="1">3.52 (3.27, 3.79)</td><td align="char" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Periventricular WM</td><td align="left" rowspan="1" colspan="1">
<bold>3.38 (3.11, 3.73)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">
<bold>3.29 (3.13, 3.46)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">3.41 (3.04, 3.69)</td><td align="char" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" rowspan="1" colspan="1">Deep WM</td><td align="left" rowspan="1" colspan="1">
<bold>2.88 (2.53, 3.41)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.77 (2.55, 3.01)</td><td align="left" rowspan="1" colspan="1">2.79 (2.31, 2.99)</td><td align="char" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Frontal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>1.62 (0.48, 2.37)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.55 (0.93, 2.08)</td><td align="left" rowspan="1" colspan="1">1.42 (0.00, 1.79)</td><td align="char" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Frontal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>1.58 (0.64, 2.52)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.70 (0.70, 2.08)</td><td align="left" rowspan="1" colspan="1">1.25 (0.00, 1.64)</td><td align="char" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>1.16 (0.64, 1.93)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">
<bold>1.21 (0.00, 1.91)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.64 (0.00, 1.27)</td><td align="char" rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>0.89 (0.00, 1.60)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.64 (0.00, 1.48)</td><td align="left" rowspan="1" colspan="1">0.64 (0.00, 1.16)</td><td align="char" rowspan="1" colspan="1">0.011</td></tr><tr><td align="left" rowspan="1" colspan="1">Parietal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>1.92 (1.25, 2.37)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.82 (1.29, 2.14)</td><td align="left" rowspan="1" colspan="1">1.56 (0.94, 2.18)</td><td align="char" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Parietal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>1.98 (1.45, 2.46)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.71 (1.08, 2.21)</td><td align="left" rowspan="1" colspan="1">1.71 (1.01, 2.20)</td><td align="char" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">Occipital lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>2.04 (1.70, 2.51)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.11 (1.78, 2.26)</td><td align="left" rowspan="1" colspan="1">1.99 (1.71, 2.33)</td><td align="char" rowspan="1" colspan="1">0.151</td></tr><tr><td align="left" rowspan="1" colspan="1">Occipital lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>2.34 (1.96, 2.64)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.17 (1.29, 2.32)</td><td align="left" rowspan="1" colspan="1">2.18 (0.89, 2.46)</td><td align="char" rowspan="1" colspan="1">0.001</td></tr><tr><td colspan="5" align="left" rowspan="1">Healthy controls [log(1+WMH volume)]</td></tr><tr><td align="left" rowspan="1" colspan="1">Whole brain</td><td align="left" rowspan="1" colspan="1">
<bold>3.29 (3.09, 3.60)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">3.29 (3.07, 3.58)</td><td align="left" rowspan="1" colspan="1">3.40 (3.10, 3.65)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Periventricular WM</td><td align="left" rowspan="1" colspan="1">
<bold>3.17 (2.80, 3.48)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">
<bold>3.10 (2.94, 3.39)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">3.23 (3.00, 3.53)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Deep WM</td><td align="left" rowspan="1" colspan="1">
<bold>2.55 (2.20, 2.92)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.59 (2.39, 2.97)</td><td align="left" rowspan="1" colspan="1">2.75 (2.36, 2.97)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Frontal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>0.89 (0.00, 1.50)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.05 (0.16, 1.96)</td><td align="left" rowspan="1" colspan="1">0.89 (0.32, 1.72)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Frontal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>0.89 (0.00, 1.58)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.28 (0.64, 2.07)</td><td align="left" rowspan="1" colspan="1">1.25 (0.00, 1.83)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Temporal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>0.00 (0.00, 1.05)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.64 (0.00, 1.01)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.00 (0.00, 0.89)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Temporal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>0.00 (0.00, 0.64)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.64 (0.00, 1.01)</td><td align="left" rowspan="1" colspan="1">0.00 (0.00, 1.21)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Parietal lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>1.39 (0.64, 1.95)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.36 (0.70, 2.00)</td><td align="left" rowspan="1" colspan="1">1.58 (0.89, 2.25)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Parietal lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>1.68 (0.89, 2.15)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1.85 (1.37, 2.21)</td><td align="left" rowspan="1" colspan="1">1.74 (1.05, 2.12)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Occipital lobe L</td><td align="left" rowspan="1" colspan="1">
<bold>1.91 (0.89, 2.28)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.07 (1.57, 2.31)</td><td align="left" rowspan="1" colspan="1">1.74 (0.77, 2.31)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Occipital lobe R</td><td align="left" rowspan="1" colspan="1">
<bold>2.11 (1.39, 2.40)</bold>
<xref rid="alz14158-tbl2-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">2.17 (1.85, 2.45)</td><td align="left" rowspan="1" colspan="1">2.34 (1.78, 2.58)</td><td align="char" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="alz14158-tbl2-note-0001"><p>Abbreviations: bvFTD: behavioral variant frontotemporal dementia; FTD, frontotemporal dementia; L, left; nfvPPA, nonfluent variant primary progressive aphasia; R, right; svPPA, semantic variant primary progressive aphasia; WM, white matter; WMH, white matter hyperintensity.</p></fn><fn id="alz14158-tbl2-note-0002"><label>
<sup>a</sup>
</label><p>Indicates that there was a significant difference in the corresponding metric between the patient group and its matched healthy controls (<italic toggle="yes">p</italic> &lt; 0.05); data represent median (25% fraction, 75% fraction).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="alz14158-sec-0200"><label>3.4</label><title>Changes in DTI‐ALPS in variants of FTD</title><p>Each of the three FTD subtypes exhibited a significantly lower DTI‐ALPS index compared to their corresponding matched HCs (mean DTI‐ALPS = 1.217 for bvFTD, mean DTI‐ALPS = 1.362 for matched HCs, FDR‐corrected <italic toggle="yes">p</italic> &lt; 0.001, Cohen's <italic toggle="yes">d</italic> = 1.233; mean DTI‐ALPS = 1.232 for nfvPPA, mean DTI‐ALPS = 1.322 for matched HCs, FDR‐corrected <italic toggle="yes">p</italic> = 0.003, Cohen's <italic toggle="yes">d</italic> = 0.796; mean DTI‐ALPS = 1.295 for svPPA, mean DTI‐ALPS = 1.364 for matched HCs, FDR‐corrected <italic toggle="yes">p</italic> = 0.034, Cohen's <italic toggle="yes">d</italic> = 0.609). ANCOVA among the three subtypes indicated noteworthy differences in the DTI‐ALPS index (<italic toggle="yes">p</italic> = 0.017). Pair‐wise intergroup comparisons revealed significant differences between svPPA and bvFTD (FDR‐corrected <italic toggle="yes">p</italic> = 0.014, Cohen's <italic toggle="yes">d</italic> = 0.678), between svPPA and nfvPPA (FDR‐corrected <italic toggle="yes">p</italic> = 0.034, Cohen's <italic toggle="yes">d</italic> = 0.564), but not between nfvPPA and bvFTD (FDR‐corrected <italic toggle="yes">p</italic> = 0.751) (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S9</xref>).</p></sec><sec id="alz14158-sec-0210"><label>3.5</label><title>Associations among imaging and clinical data</title><p>In patients with FTD, higher cortical thickness related to lower CDR scores (<italic toggle="yes">r</italic> = −0.312, FDR‐corrected <italic toggle="yes">p</italic> = 0.006) (Figure <xref rid="alz14158-fig-0005" ref-type="fig">5A</xref>) and higher MMSE score (<italic toggle="yes">r</italic> = 0.228, FDR‐corrected <italic toggle="yes">p</italic> = 0.029); higher LGI related to lower CDR score (<italic toggle="yes">r</italic> = −0.285, FDR‐corrected <italic toggle="yes">p</italic> = 0.008); higher surface area related to lower CDR score (<italic toggle="yes">r</italic> = −0.205, FDR‐corrected <italic toggle="yes">p</italic> = 0.043); higher volume of WMH across the whole brain related to higher CDR score (<italic toggle="yes">r</italic> = 0.227, FDR‐corrected <italic toggle="yes">p</italic> = 0.029) and lower MMSE score (<italic toggle="yes">r</italic> = −0.275, FDR‐corrected <italic toggle="yes">p</italic> = 0.010) (Figure <xref rid="alz14158-fig-0005" ref-type="fig">5B</xref>). Higher volume of WMH across the whole brain related to lower cortical thickness (<italic toggle="yes">r</italic> = −0.169, uncorrected <italic toggle="yes">p</italic> = 0.044), surface area (<italic toggle="yes">r</italic> = −0.243, FDR‐corrected <italic toggle="yes">p</italic> = 0.016), and LGI (<italic toggle="yes">r</italic> = −0.268, FDR‐corrected <italic toggle="yes">p</italic> = 0.011) (Figure <xref rid="alz14158-fig-0005" ref-type="fig">5C</xref>) in the patients with FTD. Lower DTI‐ALPS related to lower cortical thickness in patients with FTD (<italic toggle="yes">r</italic> = 0.318, FDR‐corrected <italic toggle="yes">p</italic> = 0.007) (Figure <xref rid="alz14158-fig-0005" ref-type="fig">5D</xref>). Whole‐brain WMH volume had a significant mediating effect on the association between cortical thickness and MMSE score, while both cortical thickness and LGI had a significant mediating effect on the association between whole‐brain WMH volume and CDR score (Figure <xref rid="alz14158-supitem-0001" ref-type="supplementary-material">S10</xref>).</p><fig position="float" fig-type="FIGURE" id="alz14158-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Correlates of imaging parameters in frontotemporal dementia (FTD). Negative correlations between cortical thickness and CDR score (A), between whole brain white matter hyperintensities (WMH) volume and Mini‐Mental State Examination (MMSE) score (B), and between whole brain WMH volume and local gyrification index (LGI) (C). (D) Positive correlation between diffusion tensor image analysis along the perivascular space (DTI‐ALPS) and cortical thickness. Functional enrichment analysis of the pivotal genes associated with greater intergroup regional deviances in cortical thickness, surface area, and LGI among the three FTD subtypes (E). Terms were retained with a threshold of false discovery rate (FDR) corrected <italic toggle="yes">p</italic> &lt; 0.05</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="ALZ-20-6045-g003.jpg"/></fig></sec><sec id="alz14158-sec-0220"><label>3.6</label><title>Neuroimaging‐transcriptional association analysis</title><p>The regional PLS1 scores, computed as a weighted sum of the 16533 gene expression dataset, demonstrated significant correlations with the <italic toggle="yes">f</italic>‐values representing regional deviations in cortical thickness, surface area, and LGI among the three FTD subtypes, accounting respectively for 51.8%, 28.4%, and 23.8% of the variance of the corresponding ANCOVA. Using a threshold of normalized weights <italic toggle="yes">Z</italic> &gt; 4, we pinpointed a collective count of 2825 pivotal genes linked to regional cortical thickness, surface area, and LGI deviances in patients with different subtypes of FTD. Utilizing the identified gene list, functional enrichment analysis unveiled an array of critical biological processes/pathways crucial to the pathophysiology of FTD, encompassing “protein phosphorylation”, “protein localization to plasma membrane”, “oxidative phosphorylation”, “fatty acid metabolism”, “MAPK pathway”, “ leukocyte activation involved in immune response”, “axonogenesis”, and “actin filament organization”, among others (Figure <xref rid="alz14158-fig-0005" ref-type="fig">5E</xref>).</p></sec></sec><sec id="alz14158-sec-0230"><label>4</label><title>DISCUSSION</title><p>Capitalizing on the multimodal MRI data of the FTLDNI, this study examined the subtype‐specific changes in cortical morphology, WMH, and perivascular glymphatic changes, as well as their interrelationships and associations with clinical data in FTD. Compared with HCs, the three FTD subtypes showed differential topographic patterns of reductions in cortical thickness, surface area, and LGI, with their global mean related to the CDR and/or MMSE scores. Compared with HCs, the bvFTD subtype showed a higher WMH volume across the whole brain, whereas such results were not found in the nfvPPA and svPPA subtypes. Using the pooled data of the three subtypes, the whole‐brain WMH volume was negatively correlated with the MMSE score and positively correlated with the CDR score. In addition, patients with FTD also showed subtype‐specific reductions in DTI‐ALPS. In FTD, higher whole‐brain WMH volume was related to lower cortical thickness, surface area, and LGI, while lower DTI‐ALPS indexing sluggish glymphatic flow was related to lower cortical thickness in FTD. Neuroimaging‐transcriptional association analysis on regional cortical morphological deviances among FTD subtypes has identified fundamental biological processes/pathways closely linked to the formation and spread of TDP‐43/tau pathologies.</p><p>Compared with HCs, we found distinct topographic patterns of cortical thickness reductions in the three FTD subtypes, which are in good agreement with previous studies.<xref rid="alz14158-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="alz14158-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Specifically, the nfvPPA subtype showed predominant thickness reductions in the bilateral frontal cortex, an area critical for language production and executive function;<xref rid="alz14158-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> the svPPA subtype showed predominant thickness reductions in the bilateral anterior and middle temporal cortex, regions that are fundamental for semantic knowledge, single word comprehension, and memory<xref rid="alz14158-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="alz14158-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="alz14158-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>; the bvFTD subtype showed more extensive thickness reductions in the bilateral frontal, temporal and parietal cortices, which involve almost all key hubs of the default mode network and have key roles in cognitive processes such as thinking, self‐awareness, executive control, and emotional processing.<xref rid="alz14158-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Using the pooled data of three subtypes, we revealed significant correlations of the global mean cortical thickness with the MMSE and CDR scores, suggesting that the cortical thickness reductions may have contributed to the cognitive impairments in FTD. In parallel, we found a similar pattern of surface area reductions as the thickness reductions in the three subtypes, although the affected cortical regions in general were less widely distributed. These results may indicate a coexistence of both radial and tangential (relative to the cortical surface) pathological changes in the FTD subtypes, with the tangential changes being relatively milder than the radial ones. This study also revealed distinct patterns of LGI reductions in the three subtypes, involving predominantly the posterior cingulate and precentral cortices in the nfvPPA subtype, the bilateral orbitofrontal and inferior frontal cortices in the svPPA subtype, and more widespread LGI reductions of the insula and neighboring areas extending to the bilateral frontal, pre‐ and post‐central and inferior parietal in the bvFTD subtype. Considering that gyrification has been thought to be a surrogate measure of underlying brain connectivity,<xref rid="alz14158-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> the observed results of LGI reductions thus may signify varying degrees of brain dysconnectivity in the three subtypes, in keeping with a previous study showing similar patterns of WM microstructural abnormalities as the LGI changes in the three subtypes.<xref rid="alz14158-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="alz14158-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> In addition, we uncovered a negative correlation between LGI and CDR score in FTD, indicating that the gyrification reduction may contribute to the progression of dementia in FTD. Intriguingly, all three subtypes exhibited frontotemporal involvement, as evidenced by changes in the three morphologic indices. This pattern likely suggests that changes in these three morphological indices could represent distinct endophenotypic manifestations of shared neuropathological abnormalities existent in relevant frontotemporal regions of FTD.</p><p>Compared with HCs, we found a higher volume of WMH across the whole brain in the bvFTD subtype but not in the nfvPPA and svPPA subtypes. This finding is in line with previous studies and indicates that the white matter lesions of FTD are subtype‐dependent.<xref rid="alz14158-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Given that the bvFTD subtype had a higher CDR score than the other two subtypes, a higher level of white matter lesions in the bvFTD subtype may, to some extent, account for the more severe dementia in this subtype. The significant correlations between whole‐brain WMH volume and MMSE score, as well as between whole‐brain WMH volume and CDR score in FTD support this speculation. We also found significant negative correlations of whole‐brain WMH volume with the global mean values of cortical thickness, surface area, and LGI in FTD, suggesting that the subtype‐specific WM lesions may have a role in the cortical morphologic changes of the three subtypes. These findings, along with the observed mediated relationships among these variables, indicate that WMH lesions affect cognitive dysfunctions in FTD by disrupting the morphology of cortical regions connected to the affected WM tracts, whereas the morphological abnormalities further exacerbate the cognitive impairments by impacting relevant WM connections. Compared with HCs, this study also revealed decreased DTI‐ALPS in the three subtypes, indicating compromised glymphatic function in FTD. The glymphatic system plays pivotal roles in the clearance of waste products (such as tau and TDP‐43 aggregates) in the brain and has been associated with MMSE scores in neurodegenerative diseases.<xref rid="alz14158-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="alz14158-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> Presumably, the compromised glymphatic function may have contributed to the dementia across the three subtypes. This speculation is partially supported by the results of the lowest DTI‐ALPS and the highest CDR score in the bvFTD subtype. The speculation, however, is at odds with our findings of the lowest CDR score (i.e., least severe dementia) but comparable DTI‐ALPS in the nfvPPA subtype compared to the bvFTD subtype. This suggests that additional pathological factors, such as WMH (being least severe in the nfvPPA subtype), may have a greater impact on the varying severity of dementia across the three subtypes. In addition, lower DTI‐ALPS was associated with lower cortical thickness in patients with FTD. This finding may indicate that the dysfunctional glymphatic system cannot effectively eliminate the continuous accumulation of toxic tau and/or TDP‐43 protein, which consequently may lead to severe neuronal losses, manifesting macroscopically as cortical thinning in FTD.</p><p>Neuroimaging‐transcriptional association analysis on regional cortical morphological deviances among the three subtypes has uncovered essential biological processes/pathways highly relevant to FTD pathologies. On the one hand, we identified a series of biological processes vital for the formation of TDP‐43 and/or tau aggregates and their intracellular transport. Specifically, the “protein phosphorylation” process, as a ubiquitous post‐translational modification of TDP‐43 and tau, could affect their activity, stability and aggregation propensity,<xref rid="alz14158-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> while the “protein localization to plasma membrane” process may have a role in the cytoplasmic mislocalization and accumulation of the predominately nuclear RNA‐binding TDP‐43.<xref rid="alz14158-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>, <xref rid="alz14158-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> Pathological changes as such can be exacerbated by disrupted cellular homeostasis that arises from a cascade of metabolic and inflammatory events. Indeed, disruptions in “oxidative phosphorylation” and “fatty acid metabolism” may elevate the level of reactive oxygen species (i.e., oxidative stress),<xref rid="alz14158-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> which likely triggers the “MAPK pathway” and initiates “leukocyte activation involved in immune response” process, culminating in a state of neuroinflammation.<xref rid="alz14158-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>, <xref rid="alz14158-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>, <xref rid="alz14158-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="alz14158-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> Such a pro‐inflammatory environment may further aggravate cytoplasmic accumulation of TDP‐43 or tau protein aggregates, which appears to interact with processes such as “axonogenesis” and “actin filament organization”, enabling their intracellular transport along axons or cellular cytoskeletal structures.<xref rid="alz14158-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>, <xref rid="alz14158-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> On the other hand, we also identified several biological processes that support intercellular communication or facilitate the exchange of biological information, such as “vesicle‐mediated transport” and “endocytosis or exocytosis”. These processes are crucial for moving macromolecules, such as proteins, from within cells to the extracellular space, and disruptions in these processes might hasten the entry of TDP‐43 and tau aggregates into the extracellular environment.<xref rid="alz14158-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>, <xref rid="alz14158-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="alz14158-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> Such detrimental effects could be amplified by the inefficient glymphatic waste clearance,<xref rid="alz14158-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> resulting in heightened extracellular accumulation and facilitating the intercellular transmission of TDP‐43 and/or tau pathologies. Altogether, these findings indicate that the cortical morphological changes observed in various FTD subtypes might represent macroscopic manifestations of disturbed biological processes or pathways that play a critical role in the development and spread of TDP‐43 and/or tau pathologies.</p><p>Some limitations should be mentioned for this study. First, the uneven sample sizes of the three patient groups may potentially affect the results of the between‐group contrasts. Second, there was a significant imbalance in the sex distribution among the three groups. Thus, sex was incorporated as a covariate of no interest to alleviate its impact on the inter‐group contrasts. Third, given that there was no significant correlation between DTI‐ALPS and clinical scores in these patients, the interpretations of the relevant results in this study are somewhat speculative and, therefore, should be taken cautiously. Fourth, the gene expression data were acquired from six <italic toggle="yes">post mortem</italic> donor brains, whereas the brain structural MRI data were obtained from 223 living participants. Such inconsistency may obscure gene expression‐cortical morphology associations with small effect sizes. Fifth, the present study was carried out cross‐sectionally. Future longitudinal studies are needed to explore the dynamic profiles of the morphologic abnormalities, WMH, and glymphatic dysfunction.</p><p>In conclusion, the present study revealed subtype‐specific changes in cortical morphologic indices, WMH and DTI‐ALPS, as well as significant associations among them in FTD. Our findings insinuate differential pathophysiology underwriting the distinct symptom profiles in the three FTD subtypes and may contribute potential pathways for the development of personalized treatment strategies for this disorder.</p></sec><sec sec-type="COI-statement" id="alz14158-sec-0250"><title>CONFLICT OF INTEREST STATEMENT</title><p>Authors declare that they have no competing interests. Author disclosures are available in the <xref rid="alz14158-supitem-0002" ref-type="supplementary-material">supporting information</xref>.</p></sec><sec id="alz14158-sec-0280"><title>CONSENT STATEMENT</title><p>Ethics approval was obtained by the FTLDNI study from the institutional review boards of all participating institutions, with all participants providing written informed consent.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="alz14158-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ALZ-20-6045-s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="alz14158-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ALZ-20-6045-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="alz14158-sec-0240"><title>ACKNOWLEDGMENTS</title><p>Data used in the preparation of this article were obtained from the Frontotemporal Lobar Degeneration Neuroimaging Initiative database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://4rtni-ftldni.ini.usc.edu/" ext-link-type="uri">https://4rtni‐ftldni.ini.usc.edu/</ext-link>). We thank the patients and their families, research volunteers, and the investigators of the Frontotemporal Lobar Degeneration Neuroimaging Initiative. This manuscript reflects the views of the authors and may not reflect the opinions or views of the database providers. LP acknowledges research support from the Canada First Research Excellence Fund, awarded to the Healthy Brains, Healthy Lives initiative at McGill University (through New Investigator Supplement to LP); Monique H. Bourgeois Chair in Developmental Disorders and Graham Boeckh Foundation (Douglas Research Centre, McGill University) and salary award from the Fonds de recherche du Quebec‐Santé (FRQS).</p></ack><sec sec-type="data-availability" id="alz14158-sec-0270"><title>DATA AVAILABILITY STATEMENT</title><p>The data that support the findings of the present study are available from the corresponding authors upon reasonable request.</p></sec><ref-list id="alz14158-bibl-0001"><title>REFERENCES</title><ref id="alz14158-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="alz14158-cit-0001"><string-name name-style="western"><surname>Boeve</surname><given-names>BF</given-names></string-name>, <string-name name-style="western"><surname>Boxer</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Kumfor</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Pijnenburg</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Rohrer</surname><given-names>JD</given-names></string-name>. <article-title>Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations</article-title>. <source>Lancet Neurol</source>. <year>2022</year>;<volume>21</volume>(<issue>3</issue>):<fpage>258</fpage>‐<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1474-4422(21)00341-0</pub-id><pub-id pub-id-type="pmid">35182511</pub-id></mixed-citation></ref><ref id="alz14158-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="alz14158-cit-0002"><string-name name-style="western"><surname>Ulugut</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pijnenburg</surname><given-names>YAL</given-names></string-name>. <article-title>Frontotemporal dementia: past, present, and future</article-title>. <source>Alzheimers Dement</source>. <year>2023</year>;<volume>19</volume>(<issue>11</issue>):<fpage>5253</fpage>‐<lpage>5263</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.13363</pub-id><pub-id pub-id-type="pmid">37379561</pub-id></mixed-citation></ref><ref id="alz14158-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="alz14158-cit-0003"><string-name name-style="western"><surname>Barker</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Gottesman</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Manoochehri</surname><given-names>M</given-names></string-name>, et al. <article-title>Proposed research criteria for prodromal behavioural variant frontotemporal dementia</article-title>. <source>Brain</source>. <year>2022</year>;<volume>145</volume>(<issue>3</issue>):<fpage>1079</fpage>‐<lpage>1097</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awab365</pub-id><pub-id pub-id-type="pmid">35349636</pub-id><pub-id pub-id-type="pmcid">PMC9050566</pub-id></mixed-citation></ref><ref id="alz14158-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="alz14158-cit-0004"><string-name name-style="western"><surname>Piguet</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Kumfor</surname><given-names>F</given-names></string-name>. <article-title>Frontotemporal dementias: main syndromes and underlying brain changes</article-title>. <source>Curr Opin Neurol</source>. <year>2020</year>;<volume>33</volume>(<issue>2</issue>):<fpage>215</fpage>‐<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1097/wco.0000000000000792</pub-id><pub-id pub-id-type="pmid">32049742</pub-id></mixed-citation></ref><ref id="alz14158-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="alz14158-cit-0005"><string-name name-style="western"><surname>Spinelli</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Mandelli</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>ZA</given-names></string-name>, et al. <article-title>Typical and atypical pathology in primary progressive aphasia variants</article-title>. <source>Ann Neurol</source>. <year>2017</year>;<volume>81</volume>(<issue>3</issue>):<fpage>430</fpage>‐<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24885</pub-id><pub-id pub-id-type="pmid">28133816</pub-id><pub-id pub-id-type="pmcid">PMC5421819</pub-id></mixed-citation></ref><ref id="alz14158-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="alz14158-cit-0006"><string-name name-style="western"><surname>Butt</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Fern</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Matute</surname><given-names>C</given-names></string-name>. <article-title>Neurotransmitter signaling in white matter</article-title>. <source>Glia</source>. <year>2014</year>;<volume>62</volume>(<issue>11</issue>):<fpage>1762</fpage>‐<lpage>1779</lpage>. doi:<pub-id pub-id-type="doi">10.1002/glia.22674</pub-id><pub-id pub-id-type="pmid">24753049</pub-id></mixed-citation></ref><ref id="alz14158-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="alz14158-cit-0007"><string-name name-style="western"><surname>Wicklund</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rademaker</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Weitner</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Weintraub</surname><given-names>S</given-names></string-name>. <article-title>Profiles of decline in activities of daily living in non‐Alzheimer dementia</article-title>. <source>Alzheimer Dis Assoc Disord</source>. <year>2007</year>;<volume>21</volume>(<issue>1</issue>):<fpage>8</fpage>‐<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1097/WAD.0b013e3180324549</pub-id><pub-id pub-id-type="pmid">17334267</pub-id></mixed-citation></ref><ref id="alz14158-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="alz14158-cit-0008"><string-name name-style="western"><surname>Hodges</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Xuereb</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kril</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Halliday</surname><given-names>G</given-names></string-name>. <article-title>Survival in frontotemporal dementia</article-title>. <source>Neurology</source>. <year>2003</year>;<volume>61</volume>(<issue>3</issue>):<fpage>349</fpage>‐<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1212/01.wnl.0000078928.20107.52</pub-id><pub-id pub-id-type="pmid">12913196</pub-id></mixed-citation></ref><ref id="alz14158-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="alz14158-cit-0009"><string-name name-style="western"><surname>Roberson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Hesse</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Rose</surname><given-names>KD</given-names></string-name>, et al. <article-title>Frontotemporal dementia progresses to death faster than Alzheimer disease</article-title>. <source>Neurology</source>. <year>2005</year>;<volume>65</volume>(<issue>5</issue>):<fpage>719</fpage>‐<lpage>725</lpage>. doi:<pub-id pub-id-type="doi">10.1212/01.wnl.0000173837.82820.9f</pub-id><pub-id pub-id-type="pmid">16157905</pub-id></mixed-citation></ref><ref id="alz14158-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="alz14158-cit-0010"><string-name name-style="western"><surname>Hodges</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Mitchell</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Dawson</surname><given-names>K</given-names></string-name>, et al. <article-title>Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases</article-title>. <source>Brain</source>. <year>2010</year>;<volume>133</volume>(pt 1):<fpage>300</fpage>‐<lpage>306</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awp248</pub-id><pub-id pub-id-type="pmid">19805492</pub-id></mixed-citation></ref><ref id="alz14158-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="alz14158-cit-0011"><string-name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lippa</surname><given-names>CF</given-names></string-name>. <article-title>Clinical subtypes of frontotemporal dementia</article-title>. <source>Am J Alzheimers Dis Other Dement</source>. <year>2015</year>;<volume>30</volume>(<issue>7</issue>):<fpage>653</fpage>‐<lpage>661</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1533317513494442</pub-id><pub-id pub-id-type="pmcid">PMC10852906</pub-id><pub-id pub-id-type="pmid">23813692</pub-id></mixed-citation></ref><ref id="alz14158-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="alz14158-cit-0012"><string-name name-style="western"><surname>Planche</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Mansencal</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Manjon</surname><given-names>JV</given-names></string-name>, et al. <article-title>Anatomical MRI staging of frontotemporal dementia variants</article-title>. <source>Alzheimers Dementia.</source> <year>2023</year>;<volume>19</volume>(<issue>8</issue>):<fpage>3283</fpage>‐<lpage>3294</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.12975</pub-id><pub-id pub-id-type="pmid">36749884</pub-id></mixed-citation></ref><ref id="alz14158-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="alz14158-cit-0013"><string-name name-style="western"><surname>Ding</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Yi</surname><given-names>L</given-names></string-name>, et al. <article-title>Association of cortical and subcortical microstructure with disease severity: impact on cognitive decline and language impairments in frontotemporal lobar degeneration</article-title>. <source>Alzheimers Res Ther</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>58</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13195-023-01208-7</pub-id><pub-id pub-id-type="pmid">36941645</pub-id><pub-id pub-id-type="pmcid">PMC10029187</pub-id></mixed-citation></ref><ref id="alz14158-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="alz14158-cit-0014"><string-name name-style="western"><surname>Savard</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pascoal</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Servaes</surname><given-names>S</given-names></string-name>, et al. <article-title>Impact of long‐ and short‐range fibre depletion on the cognitive deficits of fronto‐temporal dementia</article-title>. <source>eLife</source>. <year>2022</year>;<volume>11</volume>:<elocation-id>e73510</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.73510</pub-id><pub-id pub-id-type="pmid">35073256</pub-id><pub-id pub-id-type="pmcid">PMC8824472</pub-id></mixed-citation></ref><ref id="alz14158-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="alz14158-cit-0015"><string-name name-style="western"><surname>Palaniyappan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liddle</surname><given-names>PF</given-names></string-name>. <article-title>Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia</article-title>. <source>Neuroimage</source>. <year>2012</year>;<volume>60</volume>(<issue>1</issue>):<fpage>693</fpage>‐<lpage>699</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.12.058</pub-id><pub-id pub-id-type="pmid">22227049</pub-id></mixed-citation></ref><ref id="alz14158-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="alz14158-cit-0016"><string-name name-style="western"><surname>Singh</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Chertkow</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lerch</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Evans</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Dorr</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Kabani</surname><given-names>NJ</given-names></string-name>. <article-title>Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease</article-title>. <source>Brain</source>. <year>2006</year>;<volume>129</volume>(pt 11):<fpage>2885</fpage>‐<lpage>2893</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awl256</pub-id><pub-id pub-id-type="pmid">17008332</pub-id></mixed-citation></ref><ref id="alz14158-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="alz14158-cit-0017"><string-name name-style="western"><surname>Agosta</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Scola</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Canu</surname><given-names>E</given-names></string-name>, et al. <article-title>White matter damage in frontotemporal lobar degeneration spectrum</article-title>. <source>Cereb Cortex.</source><year>2012</year>;<volume>22</volume>(<issue>12</issue>):<fpage>2705</fpage>‐<lpage>2714</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhr288</pub-id><pub-id pub-id-type="pmid">21988828</pub-id></mixed-citation></ref><ref id="alz14158-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="alz14158-cit-0018"><string-name name-style="western"><surname>Huynh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Piguet</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Kwok</surname><given-names>J</given-names></string-name>, et al. <article-title>Clinical and biological correlates of white matter hyperintensities in patients with behavioral‐variant frontotemporal dementia and Alzheimer disease</article-title>. <source>Neurology</source>. <year>2021</year>;<volume>96</volume>(<issue>13</issue>):<fpage>e1743</fpage>‐<lpage>e1754</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.0000000000011638</pub-id><pub-id pub-id-type="pmid">33597290</pub-id></mixed-citation></ref><ref id="alz14158-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="alz14158-cit-0019"><string-name name-style="western"><surname>Wang</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>WB</given-names></string-name>, et al. <article-title>Enlarged perivascular spaces and white matter hyperintensities in patients with frontotemporal lobar degeneration syndromes</article-title>. <source>Front Aging Neurosci</source>. <year>2022</year>;<volume>14</volume>:<elocation-id>923193</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2022.923193</pub-id><pub-id pub-id-type="pmid">35966773</pub-id><pub-id pub-id-type="pmcid">PMC9366845</pub-id></mixed-citation></ref><ref id="alz14158-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="alz14158-cit-0020"><string-name name-style="western"><surname>Paternicò</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Premi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gazzina</surname><given-names>S</given-names></string-name>, et al. <article-title>White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations</article-title>. <source>Neurobiol Aging</source>. <year>2016</year>;<volume>38</volume>:<fpage>176</fpage>‐<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.11.011</pub-id><pub-id pub-id-type="pmid">26827655</pub-id></mixed-citation></ref><ref id="alz14158-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="alz14158-cit-0021"><string-name name-style="western"><surname>Sudre</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Bocchetta</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cash</surname><given-names>D</given-names></string-name>, et al. <article-title>White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort</article-title>. <source>Neuroimage Clin</source>. <year>2017</year>;<volume>15</volume>:<fpage>171</fpage>‐<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2017.04.015</pub-id><pub-id pub-id-type="pmid">28529873</pub-id><pub-id pub-id-type="pmcid">PMC5429247</pub-id></mixed-citation></ref><ref id="alz14158-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="alz14158-cit-0022"><string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>HQ</given-names></string-name>, et al. <article-title>Associations of circulating metabolites with cerebral white matter hyperintensities</article-title>. <source>J Neurochem</source>. <year>2023</year>;<volume>166</volume>(<issue>2</issue>):<fpage>414</fpage>‐<lpage>423</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.15845</pub-id><pub-id pub-id-type="pmid">37222503</pub-id></mixed-citation></ref><ref id="alz14158-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="alz14158-cit-0023"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Qu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yi</surname><given-names>X</given-names></string-name>, et al. <article-title>Sensorimotor and pain‐related alterations of the gray matter and white matter in type 2 diabetic patients with peripheral neuropathy</article-title>. <source>Hum Brain Mapp</source>. <year>2020</year>;<volume>41</volume>(<issue>3</issue>):<fpage>710</fpage>‐<lpage>725</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.24834</pub-id><pub-id pub-id-type="pmid">31663232</pub-id><pub-id pub-id-type="pmcid">PMC7268085</pub-id></mixed-citation></ref><ref id="alz14158-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="alz14158-cit-0024"><string-name name-style="western"><surname>Roher</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Kuo</surname><given-names>YM</given-names></string-name>, <string-name name-style="western"><surname>Esh</surname><given-names>C</given-names></string-name>, et al. <article-title>Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease</article-title>. <source>Mol Med</source>. <year>2003</year>;<volume>9</volume>(<issue>3‐4</issue>):<fpage>112</fpage>‐<lpage>122</lpage>.<pub-id pub-id-type="pmid">12865947</pub-id><pub-id pub-id-type="pmcid">PMC1430731</pub-id></mixed-citation></ref><ref id="alz14158-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="alz14158-cit-0025"><string-name name-style="western"><surname>Jiang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kong</surname><given-names>Y</given-names></string-name>, et al. <article-title>Regional glymphatic abnormality in behavioral variant frontotemporal dementia</article-title>. <source>Ann Neurol</source>. <year>2023</year>;<volume>94</volume>(<issue>3</issue>):<fpage>442</fpage>‐<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.26710</pub-id><pub-id pub-id-type="pmid">37243334</pub-id><pub-id pub-id-type="pmcid">PMC10657235</pub-id></mixed-citation></ref><ref id="alz14158-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="alz14158-cit-0026"><string-name name-style="western"><surname>Younes</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>BL</given-names></string-name>. <article-title>Frontotemporal dementia: neuropathology, genetics, neuroimaging, and treatments</article-title>. <source>Psychiatr Clin North Am</source>. <year>2020</year>;<volume>43</volume>(<issue>2</issue>):<fpage>331</fpage>‐<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psc.2020.02.006</pub-id><pub-id pub-id-type="pmid">32439025</pub-id></mixed-citation></ref><ref id="alz14158-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="alz14158-cit-0027"><string-name name-style="western"><surname>Ishida</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yamada</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Nishiyama</surname><given-names>R</given-names></string-name>, et al. <article-title>Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration</article-title>. <source>J Exp Med</source>. <year>2022</year>;<volume>219</volume>(<issue>3</issue>):<elocation-id>e20211275</elocation-id>. doi:<pub-id pub-id-type="doi">10.1084/jem.20211275</pub-id><pub-id pub-id-type="pmid">35212707</pub-id><pub-id pub-id-type="pmcid">PMC8932543</pub-id></mixed-citation></ref><ref id="alz14158-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="alz14158-cit-0028"><string-name name-style="western"><surname>Plog</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Nedergaard</surname><given-names>M</given-names></string-name>. <article-title>The glymphatic system in central nervous system health and disease: past, present, and future</article-title>. <source>Annu Rev Pathol</source>. <year>2018</year>;<volume>13</volume>:<fpage>379</fpage>‐<lpage>394</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-pathol-051217-111018</pub-id><pub-id pub-id-type="pmid">29195051</pub-id><pub-id pub-id-type="pmcid">PMC5803388</pub-id></mixed-citation></ref><ref id="alz14158-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="alz14158-cit-0029"><string-name name-style="western"><surname>Ringstad</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Vatnehol</surname><given-names>SAS</given-names></string-name>, <string-name name-style="western"><surname>Eide</surname><given-names>PK</given-names></string-name>. <article-title>Glymphatic MRI in idiopathic normal pressure hydrocephalus</article-title>. <source>Brain</source>. <year>2017</year>;<volume>140</volume>(<issue>10</issue>):<fpage>2691</fpage>‐<lpage>2705</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awx191</pub-id><pub-id pub-id-type="pmid">28969373</pub-id><pub-id pub-id-type="pmcid">PMC5841149</pub-id></mixed-citation></ref><ref id="alz14158-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="alz14158-cit-0030"><string-name name-style="western"><surname>Nedergaard</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Goldman</surname><given-names>SA</given-names></string-name>. <article-title>Glymphatic failure as a final common pathway to dementia</article-title>. <source>Science</source>. <year>2020</year>;<volume>370</volume>(<issue>6512</issue>):<fpage>50</fpage>‐<lpage>56</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.abb8739</pub-id><pub-id pub-id-type="pmid">33004510</pub-id><pub-id pub-id-type="pmcid">PMC8186542</pub-id></mixed-citation></ref><ref id="alz14158-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="alz14158-cit-0031"><string-name name-style="western"><surname>Faber</surname><given-names>R</given-names></string-name>. <article-title>Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria</article-title>. <source>Neurology</source>. <year>1999</year>;<volume>53</volume>(<issue>5</issue>):<fpage>1159</fpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.53.5.1158-b</pub-id><pub-id pub-id-type="pmid">10496296</pub-id></mixed-citation></ref><ref id="alz14158-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="alz14158-cit-0032"><string-name name-style="western"><surname>Palaniyappan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Marques</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>H</given-names></string-name>, et al. <article-title>Cortical folding defects as markers of poor treatment response in first‐episode psychosis</article-title>. <source>JAMA Psychiatry</source>. <year>2013</year>;<volume>70</volume>(<issue>10</issue>):<fpage>1031</fpage>‐<lpage>1040</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.203</pub-id><pub-id pub-id-type="pmid">23945954</pub-id><pub-id pub-id-type="pmcid">PMC7617342</pub-id></mixed-citation></ref><ref id="alz14158-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="alz14158-cit-0033"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>C</given-names></string-name>, et al. <article-title>Association of cortical gyrification with imaging and serum biomarkers in patients with Parkinson disease</article-title>. <source>Neurology</source>. <year>2023</year>;<volume>101</volume>(<issue>3</issue>):<fpage>e311</fpage>‐<lpage>e323</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.0000000000207410</pub-id><pub-id pub-id-type="pmid">37268433</pub-id><pub-id pub-id-type="pmcid">PMC10382266</pub-id></mixed-citation></ref><ref id="alz14158-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="alz14158-cit-0034"><string-name name-style="western"><surname>Maier</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Greuel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hoock</surname><given-names>M</given-names></string-name>, et al. <article-title>Impaired self‐awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction</article-title>. <source>Psychol Med</source>. <year>2023</year>;<volume>53</volume>(<issue>4</issue>):<fpage>1244</fpage>‐<lpage>1253</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0033291721002725</pub-id><pub-id pub-id-type="pmid">37010224</pub-id><pub-id pub-id-type="pmcid">PMC10009405</pub-id></mixed-citation></ref><ref id="alz14158-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="alz14158-cit-0035"><string-name name-style="western"><surname>Jiang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>W</given-names></string-name>, et al. <article-title>UBO detector—a cluster‐based, fully automated pipeline for extracting white matter hyperintensities</article-title>. <source>Neuroimage</source>. <year>2018</year>;<volume>174</volume>:<fpage>539</fpage>‐<lpage>549</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.03.050</pub-id><pub-id pub-id-type="pmid">29578029</pub-id></mixed-citation></ref><ref id="alz14158-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="alz14158-cit-0036"><string-name name-style="western"><surname>Taoka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Masutani</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kawai</surname><given-names>H</given-names></string-name>, et al. <article-title>Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI‐ALPS) in Alzheimer's disease cases</article-title>. <source>Jpn J Radiol.</source> <year>2017</year>;<volume>35</volume>(<issue>4</issue>):<fpage>172</fpage>‐<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11604-017-0617-z</pub-id><pub-id pub-id-type="pmid">28197821</pub-id></mixed-citation></ref><ref id="alz14158-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="alz14158-cit-0037"><string-name name-style="western"><surname>Illán‐Gala</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Montal</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Borrego‐Écija</surname><given-names>S</given-names></string-name>, et al. <article-title>Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy</article-title>. <source>Brain</source>. <year>2019</year>;<volume>142</volume>(<issue>4</issue>):<fpage>1121</fpage>‐<lpage>1133</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awz031</pub-id><pub-id pub-id-type="pmid">30906945</pub-id><pub-id pub-id-type="pmcid">PMC6439330</pub-id></mixed-citation></ref><ref id="alz14158-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="alz14158-cit-0038"><string-name name-style="western"><surname>Gorno‐Tempini</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Dronkers</surname><given-names>NF</given-names></string-name>, <string-name name-style="western"><surname>Rankin</surname><given-names>KP</given-names></string-name>, et al. <article-title>Cognition and anatomy in three variants of primary progressive aphasia</article-title>. <source>Ann Neurol</source>. <year>2004</year>;<volume>55</volume>(<issue>3</issue>):<fpage>335</fpage>‐<lpage>346</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.10825</pub-id><pub-id pub-id-type="pmid">14991811</pub-id><pub-id pub-id-type="pmcid">PMC2362399</pub-id></mixed-citation></ref><ref id="alz14158-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="alz14158-cit-0039"><string-name name-style="western"><surname>Gorno‐Tempini</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Hillis</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Weintraub</surname><given-names>S</given-names></string-name>, et al. <article-title>Classification of primary progressive aphasia and its variants</article-title>. <source>Neurology</source>. <year>2011</year>;<volume>76</volume>(<issue>11</issue>):<fpage>1006</fpage>‐<lpage>1014</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e31821103e6</pub-id><pub-id pub-id-type="pmid">21325651</pub-id><pub-id pub-id-type="pmcid">PMC3059138</pub-id></mixed-citation></ref><ref id="alz14158-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="alz14158-cit-0040"><string-name name-style="western"><surname>Hodges</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>R</given-names></string-name>, et al. <article-title>The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study</article-title>. <source>Neuropsychology</source>. <year>1999</year>;<volume>13</volume>(<issue>1</issue>):<fpage>31</fpage>‐<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1037//0894-4105.13.1.31</pub-id><pub-id pub-id-type="pmid">10067773</pub-id></mixed-citation></ref><ref id="alz14158-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="alz14158-cit-0041"><string-name name-style="western"><surname>Olney</surname><given-names>NT</given-names></string-name>, <string-name name-style="western"><surname>Spina</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>BL</given-names></string-name>. <article-title>Frontotemporal dementia</article-title>. <source>Neurol Clin</source>. <year>2017</year>;<volume>35</volume>(<issue>2</issue>):<fpage>339</fpage>‐<lpage>374</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ncl.2017.01.008</pub-id><pub-id pub-id-type="pmid">28410663</pub-id><pub-id pub-id-type="pmcid">PMC5472209</pub-id></mixed-citation></ref><ref id="alz14158-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="alz14158-cit-0042"><string-name name-style="western"><surname>Rankin</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Baldwin</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pace‐Savitsky</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kramer</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>BL</given-names></string-name>. <article-title>Self awareness and personality change in dementia</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2005</year>;<volume>76</volume>(<issue>5</issue>):<fpage>632</fpage>‐<lpage>639</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.2004.042879</pub-id><pub-id pub-id-type="pmid">15834018</pub-id><pub-id pub-id-type="pmcid">PMC1739614</pub-id></mixed-citation></ref><ref id="alz14158-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="alz14158-cit-0043"><string-name name-style="western"><surname>Ghirelli</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tafuri</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Urso</surname><given-names>D</given-names></string-name>, et al. <article-title>Cortical signature of depressive symptoms in frontotemporal dementia: a surface‐based analysis</article-title>. <source>Ann Clin Transl Neurol</source>. <year>2023</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1704</fpage>‐<lpage>1713</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.51860</pub-id><pub-id pub-id-type="pmid">37522381</pub-id><pub-id pub-id-type="pmcid">PMC10578898</pub-id></mixed-citation></ref><ref id="alz14158-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="alz14158-cit-0044"><string-name name-style="western"><surname>Kamagata</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Andica</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Takabayashi</surname><given-names>K</given-names></string-name>, et al. <article-title>Association of MRI indices of glymphatic system with amyloid deposition and cognition in mild cognitive impairment and Alzheimer disease</article-title>. <source>Neurology</source>. <year>2022</year>;<volume>99</volume>(<issue>24</issue>):<fpage>e2648</fpage>‐<lpage>e2660</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.0000000000201300</pub-id><pub-id pub-id-type="pmid">36123122</pub-id><pub-id pub-id-type="pmcid">PMC9757870</pub-id></mixed-citation></ref><ref id="alz14158-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="alz14158-cit-0045"><string-name name-style="western"><surname>Espargaró</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sabate</surname><given-names>R</given-names></string-name>. <article-title>Phosphorylation‐driven aggregative proteins in neurodegenerative diseases: implications and therapeutics</article-title>. <source>Neural Regen Res</source>. <year>2024</year>;<volume>19</volume>(<issue>5</issue>):<fpage>966</fpage>‐<lpage>968</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1673-5374.382250</pub-id><pub-id pub-id-type="pmid">37862191</pub-id><pub-id pub-id-type="pmcid">PMC10749613</pub-id></mixed-citation></ref><ref id="alz14158-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="alz14158-cit-0046"><string-name name-style="western"><surname>Liachko</surname><given-names>NF</given-names></string-name>, <string-name name-style="western"><surname>McMillan</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Strovas</surname><given-names>TJ</given-names></string-name>, et al. <article-title>The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP‐43</article-title>. <source>PLoS Genet</source>. <year>2014</year>;<volume>10</volume>(<issue>12</issue>):<elocation-id>e1004803</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1004803</pub-id><pub-id pub-id-type="pmid">25473830</pub-id><pub-id pub-id-type="pmcid">PMC4256087</pub-id></mixed-citation></ref><ref id="alz14158-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="alz14158-cit-0047"><string-name name-style="western"><surname>Ayala</surname><given-names>YM</given-names></string-name>, <string-name name-style="western"><surname>Zago</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>D'Ambrogio</surname><given-names>A</given-names></string-name>, et al. <article-title>Structural determinants of the cellular localization and shuttling of TDP‐43</article-title>. <source>J Cell Sci</source>. <year>2008</year>;<volume>121</volume>(pt 22):<fpage>3778</fpage>‐<lpage>3785</lpage>. doi:<pub-id pub-id-type="doi">10.1242/jcs.038950</pub-id><pub-id pub-id-type="pmid">18957508</pub-id></mixed-citation></ref><ref id="alz14158-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="alz14158-cit-0048"><string-name name-style="western"><surname>Rajaratnam</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Soman</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Phalguna</surname><given-names>KS</given-names></string-name>, et al. <article-title>Integrated omic analysis delineates pathways modulating toxic TDP‐43 protein aggregates in amyotrophic lateral sclerosis</article-title>. <source>Cells.</source><year>2023</year>;<volume>12</volume>(<issue>9</issue>). doi:<pub-id pub-id-type="doi">10.3390/cells12091228</pub-id><pub-id pub-id-type="pmcid">PMC10177613</pub-id><pub-id pub-id-type="pmid">37174628</pub-id></mixed-citation></ref><ref id="alz14158-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="alz14158-cit-0049"><string-name name-style="western"><surname>Chen‐Plotkin</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Geser</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Plotkin</surname><given-names>JB</given-names></string-name>, et al. <article-title>Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration</article-title>. <source>Hum Mol Genet</source>. <year>2008</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1349</fpage>‐<lpage>1362</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddn023</pub-id><pub-id pub-id-type="pmid">18223198</pub-id><pub-id pub-id-type="pmcid">PMC2900863</pub-id></mixed-citation></ref><ref id="alz14158-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="alz14158-cit-0050"><string-name name-style="western"><surname>Ayala</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Granado‐Serrano</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Cacabelos</surname><given-names>D</given-names></string-name>, et al. <article-title>Cell stress induces TDP‐43 pathological changes associated with ERK1/2 dysfunction: implications in ALS</article-title>. <source>Acta Neuropathol</source>. <year>2011</year>;<volume>122</volume>(<issue>3</issue>):<fpage>259</fpage>‐<lpage>270</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-011-0850-y</pub-id><pub-id pub-id-type="pmid">21706176</pub-id></mixed-citation></ref><ref id="alz14158-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="alz14158-cit-0051"><string-name name-style="western"><surname>Bottero</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Alrafati</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Santiago</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Potashkin</surname><given-names>JA</given-names></string-name>. <article-title>Transcriptomic and network meta‐analysis of frontotemporal dementias</article-title>. <source>Front Mol Neurosci.</source> <year>2021</year>;<volume>14</volume>:<elocation-id>747798</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fnmol.2021.747798</pub-id><pub-id pub-id-type="pmid">34720873</pub-id><pub-id pub-id-type="pmcid">PMC8554122</pub-id></mixed-citation></ref><ref id="alz14158-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="alz14158-cit-0052"><string-name name-style="western"><surname>Bright</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>van Hummel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ittner</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Ke</surname><given-names>YD</given-names></string-name>. <article-title>TDP‐43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>15</issue>). doi:<pub-id pub-id-type="doi">10.3390/ijms22157781</pub-id><pub-id pub-id-type="pmcid">PMC8346169</pub-id><pub-id pub-id-type="pmid">34360544</pub-id></mixed-citation></ref><ref id="alz14158-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="alz14158-cit-0053"><string-name name-style="western"><surname>Oberstadt</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Claßen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Arendt</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Holzer</surname><given-names>M</given-names></string-name>. <article-title>TDP‐43 and cytoskeletal proteins in ALS</article-title>. <source>Mol Neurobiol</source>. <year>2018</year>;<volume>55</volume>(<issue>4</issue>):<fpage>3143</fpage>‐<lpage>3151</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12035-017-0543-1</pub-id><pub-id pub-id-type="pmid">28466273</pub-id></mixed-citation></ref><ref id="alz14158-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="alz14158-cit-0054"><string-name name-style="western"><surname>Alami</surname><given-names>NH</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Carrasco</surname><given-names>MA</given-names></string-name>, et al. <article-title>Axonal transport of TDP‐43 mRNA granules is impaired by ALS‐causing mutations</article-title>. <source>Neuron</source>. <year>2014</year>;<volume>81</volume>(<issue>3</issue>):<fpage>536</fpage>‐<lpage>543</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.018</pub-id><pub-id pub-id-type="pmid">24507191</pub-id><pub-id pub-id-type="pmcid">PMC3939050</pub-id></mixed-citation></ref><ref id="alz14158-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="alz14158-cit-0055"><string-name name-style="western"><surname>Ratajczak</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wysoczynski</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hayek</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Janowska‐Wieczorek</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ratajczak</surname><given-names>MZ</given-names></string-name>. <article-title>Membrane‐derived microvesicles: important and underappreciated mediators of cell‐to‐cell communication</article-title>. <source>Leukemia</source>. <year>2006</year>;<volume>20</volume>(<issue>9</issue>):<fpage>1487</fpage>‐<lpage>1495</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.leu.2404296</pub-id><pub-id pub-id-type="pmid">16791265</pub-id></mixed-citation></ref><ref id="alz14158-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="alz14158-cit-0056"><string-name name-style="western"><surname>Fung</surname><given-names>KYY</given-names></string-name>, <string-name name-style="western"><surname>Fairn</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>WL</given-names></string-name>. <article-title>Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities</article-title>. <source>Traffic</source>. <year>2018</year>;<volume>19</volume>(<issue>1</issue>):<fpage>5</fpage>‐<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1111/tra.12533</pub-id><pub-id pub-id-type="pmid">28985008</pub-id></mixed-citation></ref><ref id="alz14158-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="alz14158-cit-0057"><string-name name-style="western"><surname>Brunello</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Merezhko</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Uronen</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Huttunen</surname><given-names>HJ</given-names></string-name>. <article-title>Mechanisms of secretion and spreading of pathological tau protein</article-title>. <source>Cell Mol Life Sci</source>. <year>2020</year>;<volume>77</volume>(<issue>9</issue>):<fpage>1721</fpage>‐<lpage>1744</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00018-019-03349-1</pub-id><pub-id pub-id-type="pmid">31667556</pub-id><pub-id pub-id-type="pmcid">PMC7190606</pub-id></mixed-citation></ref><ref id="alz14158-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="alz14158-cit-0058"><string-name name-style="western"><surname>Radford</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Morsch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rayner</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Pountney</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>RS</given-names></string-name>. <article-title>The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia</article-title>. <source>Front Cell Neurosci</source>. <year>2015</year>;<volume>9</volume>:<fpage>414</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2015.00414</pub-id><pub-id pub-id-type="pmid">26578880</pub-id><pub-id pub-id-type="pmcid">PMC4621294</pub-id></mixed-citation></ref></ref-list><app-group><app id="alz14158-app-0001" content-type="APPENDIX"><sec id="alz14158-sec-0290"><title>Collaborators</title><p>The principal investigator of the Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI), Howard Rosen, MD, at the University of California, San Francisco.</p></sec></app></app-group></back></article>